Daiichi Sankyo To Use Venezuela Presence To Market Ranbaxy Generics
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo and its Ranbaxy Laboratories unit have decided to do their own distribution of Ranbaxy generics in Venezuela, using what they called a "hybrid business model."